Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety & Immunogenicity of Immunisations With EN41-UGR7C HIV Vaccine

This study has been completed.
Sponsor:
Collaborator:
European Commission
Information provided by (Responsible Party):
PX'Therapeutics
ClinicalTrials.gov Identifier:
NCT01827397
First received: April 4, 2013
Last updated: May 20, 2014
Last verified: May 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2014
  Primary Completion Date: November 2013 (Final data collection date for primary outcome measure)